Back to Agendas
The Future of Clinical Trial Data Sharing
Session Chair(s)
Stephen P. Spielberg, MD, PhD
Editor-in-Chief, DIA, United States
The movement to enhance clinical trial transparency is a game changer for the industry. Recently, the Institute of Medicine (IOM) issued a report entitled Sharing Clinical Trial Data-Maximizing Benefits, Minimizing Risk that detailed guiding principles and a framework that included activities and strategies in sharing clinical trial data. Industry response has been positive as this could help reduce unnecessary data duplication, advance research and improve clinical care. But what are some of the barriers and roadblocks ahead, such as privacy and proprietary concerns or IT challenges (as an example) that may affect the future of clinical trial data sharing?
Submit your thoughts and questions to this distinguished panel by emailing annualmeetingprogram@diaglobal.org; subject The Future of Clinical Trial Data Sharing Q/A.
Learning Objective : Identify potential barriers to the sharing of clinical trial data; Describe how these barriers may affect the future of clinical trial data sharing.
Speaker(s)
Panelist
Joanne Waldstreicher, MD
Chief Medical Officer, Johnson & Johnson, United States
Panelist
Jarilyn Dupont, JD
Director of Regulatory Policy, Office of Policy, OC, FDA, United States
Panelist
David Eichmann, PhD
Director, Library Science & Info Science; Chair, Graduate Program Informatics , University of Iowa, United States
Panelist
Michael Rosenblatt, MD
Advisory Partner, Ascenta Capital, United States
Panelist
Andrzej Rys, MD
Principal Scientific Advisor, European Commission, European Union, Belgium
Have an account?